Policy & Procedure Document

PART VI — INSTRUMENTS, EQUIPMENT, AND TECHNOLOGY (HCT / FMS)
SEC 12 — Surgical Instruments & Equipment (Independent Policies)

Operating Theatre Policy

POLICY 12.1 — Care & Handling of Instruments and Equipment

Department Operating Theatre (OT)
General Hospital
Version & Dates Version: 1.0
Effective: //20__
Review: //20__
Owner OT Nurse Manager + CSSD Manager + OT QPS Lead
Policy Code
Related: SEC 9 (IPC), SEC 12.2 (Loaners), SEC 12.5 (Remove from service), CSSD policies

1.0 PURPOSE

1.1 To ensure safe, consistent point-of-use (POU) care, handling, containment, and transport of surgical instruments and powered equipment from the sterile field to CSSD, protecting:

  • a) patient safety (reprocessing quality),
  • b) staff safety (sharps/exposure control), and
  • c) asset integrity (instrument protection).

POU instrument care and controlled transport are emphasized in perioperative and sterile processing guidance. (Aorn.org)

2.0 SCOPE

  • 2.1 Applies to all reusable instruments, trays, powered devices, endoscopic instruments (OT-side handling only), and accessory equipment used in OT and OT-governed procedural rooms.
  • 2.2 Covers point-of-use treatment, segregation, transport to CSSD, and immediate containment requirements.

3.0 DEFINITIONS

  • 3.1 Point-of-Use (POU) Care: Immediate actions at the sterile field to remove gross soil, prevent drying, protect lumens, and prepare for safe transport. (Aorn.org)
  • 3.2 Containment: Use of closed/covered, leak-resistant containers to move contaminated items safely. (AAMI Array)
  • 3.3 IFU: Manufacturer instructions for use; reprocessing must follow IFU.

4.0 POLICY STATEMENT

  • 4.1 Instruments and reusable equipment shall receive POU care immediately after use to prevent drying of soil and improve cleaning effectiveness. (Aorn.org)
  • 4.2 Contaminated instruments shall be contained and transported in covered, labeled containers using defined dirty routes; clean/dirty separation must be maintained. (AAMI Array)
  • 4.3 Liquids used at point of use shall not be transported in open containers; any soaking solution must be managed to prevent spill/exposure and follow facility rule. (Aorn.org)
  • 4.4 Sharp protection is mandatory: sharps are secured; blades/needles are not transported loose.
  • 4.5 Instruments/equipment with damage, malfunction, or missing components are removed from service and tagged per Policy 12.5.

5.0 RESPONSIBILITIES

  • 5.1 Scrub Nurse/Technologist: performs sterile-field POU care, organizes instruments, protects tips, controls sharps, communicates special handling needs.
  • 5.2 Circulating Nurse: ensures safe containment, labeling, route control, and documentation (loaner tracking slip, missing items report).
  • 5.3 OT Charge Nurse: ensures supplies (transport bins, lids, moisture towels/approved sprays per IFU), ensures compliance and escalation.
  • 5.4 CSSD: receives, logs, and processes items per IFU; reports nonconformities.

6.0 PROCEDURE

6.1 Standard POU Care (During and Immediately After Case)

  • 6.1.1 Remove gross soil from instruments as they come off the field; wipe visible blood/tissue with approved method. POU care includes wiping and flushing lumens with sterile water when appropriate and per facility practice. (Aorn.org)
  • 6.1.2 Keep hinged instruments open; separate delicate instruments; protect tips and cutting edges. (ST79-related summaries emphasize correct handling/opening for effective processing.) (Healthmark, A Getinge company)
  • 6.1.3 Lumened instruments: flush per IFU/OT protocol; prevent drying of internal channels.
  • 6.1.4 Do not allow instruments to sit dry on back tables for prolonged periods; follow OT workflow to move to containment promptly.

6.2 Segregation and Count/Completeness Interface

  • 6.2.1 Separate disposable sharps and waste from reusable items at point of use. (AAMI Array)
  • 6.2.2 Verify instrument set integrity against tray list when required (especially loaners and complex sets).

6.3 Containment and Transport to CSSD

  • 6.3.1 Place contaminated instruments in closed/covered, leak-resistant containers; label as contaminated/biohazard per facility policy. (AAMI Array)
  • 6.3.2 Do not hand-carry loose instruments through corridors.
  • 6.3.3 Use defined dirty routes; avoid crossing clean supply corridors.

6.4 Powered Equipment and Special Devices

  • 6.4.1 Handle powered devices per IFU; remove batteries when required; protect connectors; send with necessary adapters and documentation.
  • 6.4.2 Any device failure triggers Policy 12.5 (remove from service/tag).

6.5 Documentation

  • 6.5.1 For all trays sent: record case, tray name, special instructions (prion risk if applicable, ophthalmic special handling, etc.).
  • 6.5.2 Loaner trays must include tracking slip and IFU confirmation (see 12.2).

7.0 RECORDS

  • 7.1 Instrument transport log/tracking slip (if used).
  • 7.2 Missing/damaged instrument report.
  • 7.3 Incident reports for exposure/spill/sharps injury.

8.0 AUDIT / KPIs

  • 8.1 POU care compliance audit. (Aorn.org)
  • 8.2 Containment compliance (covered bins, correct route). (AAMI Array)
  • 8.3 Damage rate per 100 trays; turnaround delays due to poor POU care.
Operating Theatre Policy

POLICY 12.2 — Loaner Instruments / Vendor Trays Governance

Department OT + CSSD + Supply Chain
Version & Dates Version: 1.0
Effective: //20__
Review: //20__
Owner OT Director/Chair + CSSD Manager + Supply Chain Lead
Policy Code OT-HCT-12.2
Related: (POU care), SEC 11.7 (Implants traceability), SEC 12.7 (Consumables/expiry)

1.0 PURPOSE

  • 1.1 To ensure vendor/loaner instrument sets are received, verified, processed, complete, and traceable—without shortcuts that compromise reprocessing quality or case safety. AORN sample policy emphasizes vendor delivery lead time and IFU availability with each delivery. (Aorn.org)
  • 1.2 To prevent case delays, missing instruments, incomplete trays, and unsafe “rush sterilization” due to late arrival.

2.0 SCOPE

  • 2.1 Applies to all loaner/consignment instrument trays and implant support sets brought by vendors for scheduled or urgent cases.

3.0 POLICY STATEMENT

  • 3.1 Loaner trays must arrive within defined lead time (minimum 24 hours before scheduled procedure start time unless OT/CSSD approve an exception). (Aorn.org)
  • 3.2 IFU must accompany the loaner set each time it is delivered. (AAMI Array)
  • 3.3 Trays are not released for use until:
    • a) inventory list verified,
    • b) cleaning/sterilization completed per IFU, and
    • c) set integrity confirmed. (Denver Health)
  • 3.4 Late trays without prior approval may be refused or case rescheduled if safe processing cannot be assured. (Aorn.org)

4.0 PROCEDURE (SUMMARY)

  • 4.1 Receiving: log date/time; verify tray count; confirm IFU; check visible soil/previous-use contamination concerns.
  • 4.2 Inventory verification: tray list and/or photos used; missing items documented immediately with vendor signature where possible. (Providence)
  • 4.3 Processing: CSSD processes per IFU; no “shortcut” sterilization due to vendor delay. (Denver Health)
  • 4.4 Release: trays released only after sterile processing release criteria met.
  • 4.5 Intra-op controls: keep labels/identifiers; ensure traceability for implants (Policy 11.7).
  • 4.6 Return: post-use inventory check; damage/missing items documented; trays returned per vendor contract.

5.0 RECORDS

  • 5.1 Loaner Tray Tracking Log + IFU confirmation form. (Aorn.org)
  • 5.2 Vendor delivery/receipt signature log.
  • 5.3 Missing/damaged item report.
Operating Theatre Policy

POLICY 12.3 — Electrosurgical Unit (Diathermy) Safety

Department Operating Theatre (OT)
General Hospital
Version & Dates Version: 1.0
Effective: //20__
Review: //20__
Owner OT Director/Chair + OT Nurse Manager + Biomed + OT QPS Lead
Policy Code
Related: SEC 11.8 (Surgical Smoke), SEC 11.1 (Theatre discipline), SEC 9 (IPC/flammables), SEC 12.5 (Remove from service), Fire safety policy, MOI documentation policy

1.0 PURPOSE | 2.0 SCOPE | 3.0 DEFINITIONS

1.0 PURPOSE

1.1 Purpose Statement

1.1.1 To ensure safe, standardized use of electrosurgical devices in the operating theatre to prevent patient and staff harm including:

  • a) thermal burns (at surgical site and at alternate sites),
  • b) return-electrode burns,
  • c) stray current injuries (insulation failure, capacitive coupling, direct coupling),
  • d) operating room fires and burns,
  • e) smoke exposure hazards, and
  • f) equipment-related electrical incidents.

Electrosurgical injuries and hazards are well-described in perioperative guidance and literature. (PMC)

1.2 Accreditation and Safety Intent

1.2.1 This policy supports safe use of surgical energy devices (AORN), occupational safety expectations for plume control (NIOSH/OSHA), and surgical fire prevention practices highlighted in Joint Commission Sentinel Event Alert 68.

2.0 SCOPE

2.1 Applies to all procedures using:

  • a) monopolar electrosurgery,
  • b) bipolar electrosurgery,
  • c) advanced bipolar vessel sealing devices,
  • d) argon beam coagulation (if used),
  • e) electrocautery pencils and accessories,
  • f) laparoscopic electrosurgery including insulated instruments, trocars, and active electrode monitoring systems.

2.2 Applies to OT staff, surgeons/proceduralists, anesthesia staff in the OR environment, biomedical/engineering support, and vendors providing device accessories.

3.0 DEFINITIONS

  • 3.1 ESU/Generator: Device producing high-frequency current for tissue effects (cut/coag).
  • 3.2 Active Electrode: Pencil/handpiece delivering energy.
  • 3.3 Return Electrode (Dispersive Electrode): Patient electrode returning current in monopolar mode; improper use can cause burns. FDA has issued recall/alerts regarding certain return electrodes due to burn risk.
  • 3.4 Stray Current Mechanisms:
    • a) insulation failure,
    • b) direct coupling,
    • c) capacitive coupling—described as mechanisms of electrothermal injury. (PMC)
  • 3.5 Fire Triangle: ignition source + oxidizer (oxygen/nitrous oxide) + fuel (drapes, alcohol prep, hair, etc.); surgical fires are strongly associated with electrosurgical devices in head/neck settings.

4.0 POLICY STATEMENT | 5.0 ROLES AND RESPONSIBILITIES

4.0 POLICY STATEMENT

  • 4.1 Electrosurgical equipment shall be used only by trained and competent staff, following manufacturer IFU and this policy. AORN guidance emphasizes IFU adherence and compatibility verification. (Aorn.org)
  • 4.2 Prior to use, the team shall verify:
    • a) device readiness and alarms,
    • b) accessory compatibility,
    • c) correct return electrode selection/placement (monopolar), and
    • d) smoke evacuation readiness for plume-generating use (link to Policy 11.8).
  • 4.3 The active electrode shall be placed in a holster/off-patient safe location when not in active use to reduce unintended activation and fire risk (reinforced in surgical fire prevention recommendations). (lhatrustfunds.com)
  • 4.4 During head/neck and oxygen-enriched field procedures, surgical fire prevention controls are mandatory; Joint Commission Alert 68 highlights this risk pattern and outlines mitigation expectations.
  • 4.5 Any equipment malfunction, abnormal heating, return-electrode alarm, unexplained burn, or suspected stray current injury triggers immediate stop, patient safety actions, device removal from service, and incident reporting. FDA recalls demonstrate that return electrode issues can cause serious burns.

5.0 ROLES AND RESPONSIBILITIES

5.1 Surgeon/Proceduralist

  • 5.1.1 Uses electrosurgery safely (lowest effective settings, activation only when intended, correct technique).
  • 5.1.2 Participates in fire risk assessment and agrees to pause when oxidizer/fuel conditions are unsafe.

5.2 Circulating Nurse (Electrosurgery Safety Coordinator per case)

  • 5.2.1 Performs ESU pre-use safety checks, verifies accessory compatibility, ensures correct return electrode placement and documentation, and ensures smoke evacuation is ready and used when plume is generated. (Aorn.org)
  • 5.2.2 Ensures active electrode holster is available and used. (lhatrustfunds.com)
  • 5.2.3 Monitors for hazards (pooling prep solution, oxygen enrichment, drape proximity, cable tension).

5.3 Scrub Nurse/Technologist

  • 5.3.1 Maintains sterile management of the active electrode, keeps the electrode tip protected, and ensures safe placement in holster when not used. (lhatrustfunds.com)
  • 5.3.2 Assists in ensuring smoke capture inlet is positioned close to the site (Policy 11.8).

5.4 Anesthesia Provider (Interface responsibilities only)

  • 5.4.1 Collaborates on fire risk controls related to oxygen delivery and oxidizer management during high-risk cases (especially head/neck).

5.5 Biomedical/Engineering

  • 5.5.1 Maintains ESUs, accessories, footswitches, cords, alarms; completes preventive maintenance/calibration and repair documentation.
  • 5.5.2 Supports investigations by testing sequestered devices.

5.6 OT Charge Nurse / OT Leadership

  • 5.6.1 Ensures training, audit program, device availability, backup plans, and compliance enforcement.

6.0 ELECTROSURGERY SAFETY PRINCIPLES | 7.0 PRE-USE SAFETY CHECKS

6.0 ELECTROSURGERY SAFETY PRINCIPLES (STANDARDIZED UNDERSTANDING)

6.1 Why burns occur (plain, practical explanation for staff)

6.1.1 In monopolar electrosurgery, current flows from active electrode → through patient → back to generator via return electrode.

6.1.2 Injury occurs when current density concentrates unexpectedly:

  • a) poor return electrode contact,
  • b) alternate return pathways (metal contact, ECG leads),
  • c) stray current from insulation failure/capacitive coupling/direct coupling. (PMC)

6.2 Stray current mechanisms (OT must recognize these patterns)

  • 6.2.1 Insulation failure: damaged insulation creates an unintended current path. (PMC)
  • 6.2.2 Direct coupling: active electrode contacts another metal instrument, energizing it. (PMC)
  • 6.2.3 Capacitive coupling: current transfers through intact insulation into adjacent conductive material, especially in MIS settings; evidence tables and literature describe this risk. (PMC)

7.0 PRE-USE SAFETY CHECKS (MANDATORY “ROOM SETUP” STANDARD)

7.1 Generator and accessory compatibility

  • 7.1.1 Confirm ESU generator model matches required accessories; AORN update emphasizes verifying ESUs and accessories compatibility and labeling accessories to correspond with each generator when multiple are used. (Aorn.org)
  • 7.1.2 Confirm correct mode availability (mono/bipolar, argon) and check footswitch assignment.
  • 7.1.3 Confirm alarm systems are functional (contact quality monitoring/return electrode monitoring if available).

7.2 Cords, cables, and insulation integrity

  • 7.2.1 Inspect active electrode cord, handpiece, and insulation for cracks, burns, exposed wiring.
  • 7.2.2 Inspect bipolar forceps cable and connector pins; ensure no bent pins.
  • 7.2.3 Remove from service any damaged accessory (Policy 12.5). (ECRI and ISMP)

7.3 Holster and safe placement

7.3.1 A holster must be present, within reach, and secured so the active electrode is never placed on the patient or drapes when not in use. (lhatrustfunds.com)

7.4 Smoke evacuation readiness (linked control)

7.4.1 For plume-generating use, ensure smoke evacuator is available and capture inlet can be placed within 2 inches of the site (Policy 11.8; OSHA/NIOSH guidance).

8.0 PATIENT ASSESSMENT AND RETURN ELECTRODE MANAGEMENT (MONOPOLAR)

8.1 Patient skin assessment before placement

  • 8.1.1 Inspect skin for: scars, burns, rashes, edema, bony prominences, hair density, tattoos, metal implants proximity, moisture, prep solution pooling risk.
  • 8.1.2 Choose a site that supports broad, uniform contact and avoids compromised skin.

8.2 Return electrode selection (type and suitability)

  • 8.2.1 Use only approved return electrodes compatible with the ESU.
  • 8.2.2 Follow age/weight restrictions for pediatric electrodes. FDA communications and recalls highlight serious burn risk with certain return electrodes and pediatric use considerations.
  • 8.2.3 Consider newer guidance on return electrode types when available; AORN 2026 update discusses preferences (e.g., dual-foil/capacitive alternatives where available) and correct placement practices. (Aorn.org)

8.3 Return electrode placement standard

8.3.1 Place on a clean, dry, well-perfused, muscular area close to the surgical site when feasible (without compromising position or sterility). AORN update emphasizes placement close to site and one pad per generator when using conductive pads. (Aorn.org)

8.3.2 Avoid placement over:

  • a) bony prominences,
  • b) scar tissue,
  • c) adipose folds where contact may be uneven,
  • d) wet/soaked linen areas,
  • e) areas near ECG electrodes or monitoring leads (alternate site burn risk).

8.3.3 Ensure full pad contact (no lifting edges); smooth outward to remove air pockets.

8.3.4 Document pad type, location, and skin condition pre- and post-case.

8.4 Multiple generators / two ESUs in one case

8.4.1 If two ESUs are used:

  • a) use one return electrode per generator unless a manufacturer-approved capacitive return electrode with appropriate dual-cord configuration is used,
  • b) label cords to correspond to each generator,
  • c) ensure pads do not overlap,
  • d) place each pad appropriately relative to its surgical site. (Aorn.org)

9.0 SAFE OPERATING PRACTICES | 10.0 MIS PRECAUTIONS

9.0 SAFE OPERATING PRACTICES (INTRAOPERATIVE)

9.1 Energy setting discipline (“lowest effective”)

  • 9.1.1 Use the lowest power setting that achieves the intended effect; avoid unnecessary high settings that increase stray energy and fire risk.
  • 9.1.2 Any change in settings is communicated clearly and documented if required by local rule.

9.2 Activation safety

  • 9.2.1 Activate only when the tip is in view and at target tissue.
  • 9.2.2 Never activate in open air (“open circuit”), especially in minimally invasive surgery; stray mechanisms are recognized hazards. (PMC)
  • 9.2.3 When not active, place electrode in holster and away from patient/drapes. (lhatrustfunds.com)

9.3 Cable and fluid management

  • 9.3.1 Keep cables dry and away from pooled fluids.
  • 9.3.2 Prevent prep solution pooling under patient or near electrode tip; alcohol-based prep is a known fuel in the fire triangle.

10.0 MINIMALLY INVASIVE SURGERY (MIS) — ENHANCED PRECAUTIONS

10.1 MIS electrosurgery presents higher risk for insulation failure and capacitive coupling injuries; AORN and literature describe these mechanisms and recommend additional precautions. (Medline)

10.2 MIS safety standard work

  • 10.2.1 Use insulated instruments in good condition; inspect insulation before use.
  • 10.2.2 Use active electrode monitoring systems when available and compatible (facility decision).
  • 10.2.3 Avoid activating energy devices when not in direct contact with target tissue.
  • 10.2.4 Avoid contact between active electrode and other metal instruments (direct coupling). (PMC)
  • 10.2.5 Maintain awareness that capacitive coupling can occur even with intact insulation; minimize prolonged activation and unintended contact with instrument shafts; evidence tables document coupling injury scenarios. (Aorn.org)

11.0 SURGICAL FIRE PREVENTION | 12.0 SMOKE CONTROL

11.0 SURGICAL FIRE PREVENTION INTERFACE (ESU IS A PRIMARY IGNITION SOURCE)

11.1 Joint Commission Sentinel Event Alert 68 highlights that most surgical fires and burns are associated with electrosurgical devices during head/neck surgery and reiterates fire triangle risk management.

11.2 Mandatory fire risk actions when ESU used

  • 11.2.1 Conduct a fire risk assessment before incision in high-risk cases (head/neck, open oxygen delivery, alcohol prep).
  • 11.2.2 Manage oxidizer: minimize supplemental oxygen concentration and avoid open oxygen flow under drapes when clinically appropriate (per anesthesia/fire policy).
  • 11.2.3 Manage fuel: ensure alcohol prep fully dries; keep sponges/drapes positioned safely; prevent pooling.
  • 11.2.4 Manage ignition: holster active electrode when not used; activate only when intended; keep hot tips away from drapes/hair. (lhatrustfunds.com)

11.3 Fire response (OT roles)

  • 11.3.1 If fire occurs: stop ignition source, announce fire, remove burning materials if safe, follow OR fire policy and drills (RACE/PASS).
  • 11.3.2 Document event and sequester involved equipment (Policy 12.5). (members.ecri.org)

12.0 SMOKE / PLUME CONTROL (LINKED TO POLICY 11.8)

12.1 Smoke evacuation must be available for rooms where plume is generated and used consistently; OSHA and NIOSH recommend local exhaust and keeping the inlet within 2 inches.

13.0 SPECIAL RISK POPULATIONS | 14.0 DEVICE FAILURE RESPONSE

13.0 SPECIAL RISK POPULATIONS AND CONDITIONS

13.1 Pediatrics

13.1.1 Follow pad/device age/weight restrictions; FDA has issued recall/alerts related to return electrode burn risks, including pediatric-specific products.

13.2 Patients with implanted electronic devices (pacemaker/ICD)

13.2.1 Follow facility pathway for perioperative management (cardiology/anesthesia lead); OT responsibilities: minimize current path crossing device, correct pad placement, ensure equipment compatibility and monitoring readiness.

13.3 Conductive contact risks

13.3.1 Prevent patient contact with metal components (OR table rails) that may create alternate return pathways; ensure padding and isolation of limbs and contact points.

14.0 DEVICE FAILURE, SUSPECTED BURN, OR ALARM RESPONSE

  • 14.1 If return electrode alarm occurs: stop activation, assess pad contact and placement, replace pad if needed, document, and notify surgeon.
  • 14.2 If unexplained skin redness/burn occurs: stop use, assess patient, document, and escalate; sequester devices and accessories for investigation.
  • 14.3 If accessory damage noted: remove from service and tag (Policy 12.5).

15.0 DOCUMENTATION | 16.0 TRAINING | 17.0 AUDIT / KPIs

15.0 DOCUMENTATION ( MINIMUM RECORD)

  • 15.1 Generator ID (asset tag) and mode(s) used.
  • 15.2 Active electrode type and key accessories used.
  • 15.3 Return electrode type, site, skin condition pre/post (monopolar).
  • 15.4 Settings (baseline and major changes if required).
  • 15.5 Smoke evacuation used (Y/N) for plume-generating cases; failure events.
  • 15.6 Any alarms, interruptions, burns, fire risk issues, corrective actions.
  • 15.7 Incident report reference for adverse events/near misses.

16.0 TRAINING AND COMPETENCY

  • 16.1 Initial training includes: circuit basics, pad placement, holster discipline, MIS stray current risks, fire prevention, smoke evacuation, and emergency response.
  • 16.2 Annual competency includes observation of: pad placement, holster use, MIS precautions, fire risk behaviors, documentation quality.
  • 16.3 Drills: surgical fire drills and equipment failure response drills as per OT/FMS plan.

17.0 AUDIT / KPIs

  • 17.1 % cases with documented return electrode site/skin check (monopolar).
  • 17.2 % cases with holster used correctly (observation).
  • 17.3 Smoke evacuation compliance in plume cases.
  • 17.4 ESU-related burn/near-miss events per 1,000 cases; trend review.
  • 17.5 Fire risk assessment compliance in head/neck oxygen cases.

18.0 REFERENCES | 19.0 APPENDICES

18.0 REFERENCES (ENGLISH)

  • 18.1 AORN: Guidelines in Practice—Electrosurgical Safety.
  • 18.2 AORN 2026 update: Safe use of surgical energy devices (return electrode practices; multi-generator guidance).
  • 18.3 Electrosurgery injury mechanisms review (insulation failure/capacitive coupling/direct coupling).
  • 18.4 Joint Commission Sentinel Event Alert 68 (updated surgical fire prevention).
  • 18.5 Patient Safety Authority advisory: ESU and surgical fire risk triangle.
  • 18.6 NIOSH guidance on surgical smoke control (LEV; on during plume).
  • 18.7 OSHA surgical smoke plume eTool (evacuate all smoke; inlet within 2 inches).
  • 18.8 FDA recall/alerts for patient return electrodes and burn risks.
  • 18.9 AORN electrosurgery recommended practices (historical reference; two-generator pad guidance).

19.0 APPENDICES (READY-TO-USE TOOLS)

  • 19.1 ESU Daily Readiness Checklist (room device check)
  • 19.2 ESU Per-Case Setup Checklist (holster, cords, alarms, smoke evacuator readiness)
  • 19.3 Return Electrode Placement Guide (adult/pediatric cautions; contraindicated sites)
  • 19.4 MIS Electrosurgery Safety Checklist (insulation/coupling precautions)
  • 19.5 Fire Risk Assessment Prompt (for head/neck and oxygen-enriched cases)
  • 19.6 ESU Event Response Form (alarm/burn/suspected stray current) + device sequester tag reference

Operating Theatre Policy

POLICY 12.4 — Warming Cabinet Use & Safety

Policy CodeOT-HCT-12.4
OwnerOT Nurse Manager + IPC + Engineering
Version & DatesVersion: 1.0 | Effective: //20__ | Review: //20__
RelatedSEC 9 (IPC), Policies 12.5/12.6, Patient temperature management

1.0 PURPOSE

  • 1.1 To ensure safe, controlled use of warming cabinets (blanket/linen warmers and IV fluid warmers) with documented temperature monitoring, segregation rules, and burn prevention.
  • 1.2 To prevent patient burns, contamination, or uncontrolled warming that compromise patient safety during perioperative care.
  • 1.3 To comply with AORN, ECRI, and facility FMS requirements for warming device management and documentation.

2.0 SCOPE

  • 2.1 Applies to all warming cabinets in the OT suite: blanket/linen warmers and IV fluid warmers.
  • 2.2 Covers all OT nursing, anaesthesia, and ancillary staff who use, monitor, or maintain warming equipment.
  • 2.3 Covers all patient care environments within the OT where warming devices are used.

3.0 POLICY STATEMENT

  • 3.1 Warming cabinets are used ONLY for approved items and within approved temperature ranges; temperatures are documented every shift.
  • 3.2 Blanket/linen warmers and fluid warmers SHALL be segregated — no mixed storage of blankets and IV fluids in the same cabinet unless the device is specifically designed for both.
  • 3.3 Maximum temperature settings follow AORN guidance: blanket warmers ≤ 43°C (110°F) surface temperature at point of patient contact; IV fluids per manufacturer IFU.
  • 3.4 Items removed from a warmer must be used within the facility-defined time window; items exceeding the hold time are removed and replaced.
  • 3.5 No improvised warming methods (microwaves, ovens, hot water baths) are permitted.
  • 3.6 Warm blankets must NEVER be applied directly to unconscious or sedated patients without a protective layer and nursing monitoring for burn risk.

4.0 PROCEDURE

4.1 Daily Checks (Each Shift)

  • Record cabinet temperature in the warming cabinet log (AM and PM check minimum).
  • Verify alarm function where applicable; confirm temperature is within prescribed range.
  • Remove any items exceeding hold time; discard or return to storage.

4.2 Loading & Use

  • Label items with date/time placed in warmer.
  • Only facility-approved items loaded; no medication storage in warming cabinets unless specifically designated and approved by pharmacy.
  • IV fluids: warm per IFU, not exceeding 40°C for routine use; record lot number for implantable-fluid traceability if applicable.

4.3 Malfunction Response

  • If temperature out of range, power failure, or alarm: remove all items immediately, tag cabinet "Remove from Service" (Policy 12.5), notify charge nurse and engineering.
  • Do not use cabinet until cleared by Biomed (Policy 12.6).

4.4 Cleaning

  • Clean cabinet interior per schedule defined by IPC (weekly minimum, or after contamination).
  • Record cleaning date in log.

5.0 DOCUMENTATION | 6.0 AUDIT / KPIs

5.0 DOCUMENTATION

  • 5.1 Warming Cabinet Daily Temperature Log (AM/PM entries per shift).
  • 5.2 Cleaning log (date, staff signature).
  • 5.3 Equipment fault/removal log entry if malfunction occurs (linked to Policy 12.5).

6.0 AUDIT / KPIs

  • 6.1 % shifts with completed temperature log ≥ 95%.
  • 6.2 Zero patient burn incidents attributable to warming cabinet use.
  • 6.3 Zero unauthorized items found in warming cabinets on monthly audit.

Operating Theatre Policy

POLICY 12.5 — Equipment Failure Response & "Remove from Service" Tagging

Policy CodeOT-HCT-12.5
OwnerOT Nurse Manager + Biomed/Engineering Lead + OT QPS Lead
Version & DatesVersion: 1.0 | Effective: //20__ | Review: //20__
RelatedSEC 3 (incident reporting), SEC 12.6 (PM), FMS medical device policy

1.0 PURPOSE

  • 1.1 To ensure any faulty, damaged, or suspect equipment is immediately removed from patient use, clearly tagged, sequestered, reported, and investigated to prevent repeat harm or near-miss.
  • 1.2 To provide a standardised "Remove from Service" (RFS) protocol that all OT personnel can apply consistently, regardless of equipment type.
  • 1.3 To comply with ECRI, AAMI, and facility FMS/CMS requirements for medical device event management.

2.0 SCOPE

  • 2.1 Applies to ALL OT equipment: ESUs, warming devices, suction units, tourniquets, positioning aids, monitors, infusion pumps, imaging equipment, and any other device used during perioperative care.
  • 2.2 Covers all OT clinical, technical, and support staff who identify or discover a device malfunction or concern.

3.0 POLICY STATEMENT

  • 3.1 Triggers for immediate RFS: malfunction, abnormal performance, alarm failure, visible physical damage, burning smell, overheating, electrical fault, fluid ingress, or any suspected contribution to patient harm.
  • 3.2 Equipment involved in a patient adverse event or near-miss must be sequestered for investigation — it must NOT be cleaned, repaired, or disposed of until cleared by the incident investigation team.
  • 3.3 No staff member may override an RFS tag or return equipment to service without written Biomed clearance.
  • 3.4 CMS / ECRI guidance: equipment settings, alarms, and interfaces with clinical environment must all be considered when evaluating failure cause.

4.0 PROCEDURE

4.1 Immediate Action (at point of discovery)

  • STOP use immediately; switch off if safe to do so.
  • Ensure patient safety — transition to backup equipment or manual alternatives if required.
  • Do NOT attempt field repair.

4.2 Tagging

  • Attach a visible "REMOVE FROM SERVICE — DO NOT USE" tag to the device.
  • Tag must include: date, time, fault description, name/signature of reporting staff.
  • Move device to the designated quarantine area or secure it in place if it cannot be moved safely.

4.3 Notification

  • Notify charge nurse immediately; charge nurse notifies Biomed/Engineering.
  • If the failure is associated with patient harm or near-miss: notify OT Director and QPS Lead; complete an incident report (SEC 3) within the required timeframe.

4.4 Investigation & Return to Service

  • Biomed inspects, diagnoses, and repairs device per PM programme (Policy 12.6).
  • Biomed issues written clearance before device is returned to OT stock.
  • OT charge nurse countersigns return-to-service log entry.

5.0 DOCUMENTATION | 6.0 AUDIT / KPIs

5.0 DOCUMENTATION

  • 5.1 Equipment Fault & RFS Log (device ID, fault, date/time, staff, biomed action, return-to-service date).
  • 5.2 Incident report if patient harm or near-miss involved (SEC 3).
  • 5.3 Biomed written clearance certificate retained in equipment file.

6.0 AUDIT / KPIs

  • 6.1 100% of RFS events documented in log within 24 hours.
  • 6.2 Zero RFS tags overridden without Biomed written clearance.
  • 6.3 Mean Biomed response time to OT equipment fault ≤ 2 hours (critical) / ≤ 24 hours (non-critical).

Operating Theatre Policy

POLICY 12.6 — Preventive Maintenance & Calibration Interface (Biomed)

Policy CodeOT-HCT-12.6
OwnerBiomedical/Engineering Lead + OT Nurse Manager
Version & DatesVersion: 1.0 | Effective: //20__ | Review: //20__
RelatedPolicy 12.5, FMS utilities policy, procurement policy, AAMI EQ56

1.0 PURPOSE

  • 1.1 To ensure all OT critical equipment is maintained, calibrated, and survey-ready through a structured Medical Equipment Management Programme (MEMP) aligned with AAMI EQ56 and applicable regional/accreditation standards.
  • 1.2 To define the interface between OT nursing staff and the Biomedical Engineering (Biomed) department regarding PM scheduling, tag verification, and removal/return-to-service workflow.
  • 1.3 To prevent equipment-related clinical events through systematic planned maintenance and timely calibration.

2.0 SCOPE

  • 2.1 Applies to all OT critical and semi-critical equipment: ESU/diathermy units, defibrillators, warming devices, suction units, tourniquet machines, smoke evacuators, infusion pumps, patient monitors, anaesthesia interface equipment, and C-arm (in coordination with Radiology).
  • 2.2 Covers Biomed Engineering, OT Nurse Manager, OT charge nurses, and ancillary technical staff.

3.0 POLICY STATEMENT

  • 3.1 All OT critical equipment is included in the Biomed inventory and PM schedule with defined frequencies (per IFU or risk-based assessment).
  • 3.2 Calibration and PM records must be available on demand for accreditation survey; records are retained per facility retention policy (minimum 3 years or as per regulatory requirement).
  • 3.3 Any equipment with an overdue PM sticker or expired calibration date is treated as "out of service" and handled per Policy 12.5.
  • 3.4 OT nursing staff must NOT perform PM tasks; their role is to verify PM tags, report missing/overdue tags, and facilitate Biomed access.
  • 3.5 New equipment introduced to OT must be commissioned by Biomed before first clinical use; no trial-based use without safety evaluation.

4.0 PROCEDURE

4.1 Biomed Responsibilities

  • Maintain asset register for all OT equipment (device ID, model, location, PM frequency, next due date).
  • Perform PM and calibration per IFU and schedule; affix PM sticker (device ID, date performed, next due date, technician ID).
  • Provide OT with monthly PM status report (overdue, due within 30 days, completed).

4.2 OT Nursing Responsibilities

  • Verify PM tag present on each device before use (daily pre-case check).
  • Report missing PM tag or overdue tag to charge nurse; tag device per Policy 12.5 if overdue.
  • Facilitate Biomed access to OT during scheduled maintenance windows (e.g., between lists).

4.3 Equipment Commissioning (New Devices)

  • Biomed performs incoming inspection and safety evaluation before first OT use.
  • Staff training completed (if required) and documented before clinical use.
  • Device added to asset register on day of commissioning.

5.0 DOCUMENTATION | 6.0 AUDIT / KPIs

5.0 DOCUMENTATION

  • 5.1 OT Equipment Asset Register (maintained by Biomed).
  • 5.2 PM and calibration records per device (Biomed file).
  • 5.3 Monthly PM status report to OT Nurse Manager.
  • 5.4 Commissioning inspection report for each new device.

6.0 AUDIT / KPIs

  • 6.1 % OT equipment with valid PM sticker at monthly audit ≥ 98%.
  • 6.2 Zero equipment used past PM due date without documented Biomed approval.
  • 6.3 100% new devices commissioned before first clinical use (zero exceptions).

Operating Theatre Policy

POLICY 12.7 — Consumables & Expiry Management

Policy CodeOT-HCT-12.7
OwnerOT Nurse Manager + Supply Chain + CSSD
Version & DatesVersion: 1.0 | Effective: //20__ | Review: //20__
RelatedSEC 10 (meds expiry), SEC 11.7 (implants traceability), SEC 9 (sterile supplies), CSSD policy

1.0 PURPOSE

  • 1.1 To prevent use of expired, compromised, or recalled consumables in the OT through reliable stock rotation, systematic expiry checks, and rapid quarantine of non-conforming items.
  • 1.2 To maintain sterile pack integrity standards and ensure implant/consumable traceability from receipt to patient use.
  • 1.3 To comply with AORN, CSSD, and facility supply chain standards for surgical consumable management.

2.0 SCOPE

  • 2.1 Applies to ALL consumables stored or used in the OT: sutures, sterile drapes/gowns, sponges, staples, absorbable haemostats, gloves, syringes, implants, and other single-use items.
  • 2.2 Covers OT nursing staff, scrub technicians, anaesthesia team (for their consumables), and supply chain/stores personnel.

3.0 POLICY STATEMENT

  • 3.1 OT shall implement FEFO/FIFO (first-expire-first-out / first-in-first-out) stock rotation for all consumables; this applies equally to ward stock, scrub trolley stock, and implant stores.
  • 3.2 Sterile pack integrity is mandatory before use: torn seals, wet packs, unknown expiry, or visible contamination renders the item non-sterile — it is removed and not used, regardless of availability pressure.
  • 3.3 Single-use items (marked SU or ♲ — no reuse symbol) must NEVER be resterilised or reused.
  • 3.4 Implant expiry, lot number, and serial number traceability must be recorded in the patient file and implant register (Policy 11.7).
  • 3.5 Recalled or field safety notice items must be quarantined immediately upon notification and removed from all OT storage locations within 2 hours.

4.0 PROCEDURE

4.1 Daily Checks (pre-list / per shift)

  • Scrub nurse checks expiry of high-risk items on scrub trolley before opening (sutures, staples, haemostats, implants for the listed case).
  • Any item expiring within 30 days moved to "short-dated" area; notified to charge nurse for priority use or return to supply chain.

4.2 Weekly Checks

  • Charge nurse or designee performs structured check of all OT store cupboards and scrub trolley stock.
  • Expired items are removed, labelled "EXPIRED — DO NOT USE", placed in quarantine bin, and documented in the expiry log.
  • Supply chain notified for replacement; waste disposed per facility protocol.

4.3 Monthly Implant Store Audit

  • OT Nurse Manager or delegate performs full physical implant inventory check.
  • Cross-check against supply chain system; document any discrepancies.
  • Items expiring within 90 days flagged for surgeon/supply chain action.

4.4 Recall Management

  • Supply chain/pharmacy issues recall alert; OT charge nurse coordinates immediate stock check.
  • All recalled items quarantined within 2 hours; lot numbers cross-checked against patient implant register.
  • Affected patients notified as per facility recall response procedure.

5.0 DOCUMENTATION | 6.0 AUDIT / KPIs

5.0 DOCUMENTATION

  • 5.1 Consumable Expiry Log (weekly entries: item, lot number, expiry date, action taken, staff signature).
  • 5.2 Implant Register (lot/serial/expiry per patient; cross-referenced with patient notes).
  • 5.3 Recall Response Record (date of alert, items found, quarantine action, patient impact assessment).

6.0 AUDIT / KPIs

  • 6.1 Zero expired consumables found in active OT stock at monthly audit.
  • 6.2 100% implant traceability (lot/serial documented per patient) at quarterly audit.
  • 6.3 Recall quarantine completion within 2 hours of alert — zero exceptions.
Operating Theatre Policy

POLICY 12.8 — IT Downtime Procedure (Paper Packs, Back-Entry Rules)

Department Operating Theatre (OT)
General Hospital
Version & Dates Version: 1.0
Effective: //20__
Review: //20__
Owner OT Nurse Manager + HIM/MOI Lead + IT Lead
Policy Code OT-MOI-12.8
Related: Policy 11.12 (Perioperative Documentation Standards), SEC 6 (Verification), SEC 10 (Medication Mgmt), Policy 11.6 (Specimens), Policy 11.7 (Implants), SEC 8 (OT→PACU Handover)

1.0 PURPOSE

1.1 Purpose Statement

  • 1.1.1 To maintain safe perioperative documentation, labeling, order/result communication, and traceability during scheduled or unscheduled Electronic Health Record (EHR) downtime by using standardized OT downtime packs and a controlled recovery/back-entry process.
  • 1.1.2 To reduce known downtime patient safety risks—especially patient identification errors, medication documentation errors, and delays in information availability—through defined roles, paper workflows, verification steps, and post-downtime reconciliation. (psnet.ahrq.gov)

2.0 SCOPE

2.1 Included

2.1.1 All OT-controlled documentation and workflows impacted by EHR unavailability, including:

  • a) patient reception/acceptance into OT,
  • b) safe surgery documentation (Sign-In/Time-Out/Sign-Out governance capture),
  • c) intraoperative OT record documentation,
  • d) surgical counts and RSI discrepancy documentation interface,
  • e) specimen labeling/logging/dispatch,
  • f) implant/prosthesis traceability capture and logs,
  • g) OT-managed medications/contrast/dyes documentation (OT scope only),
  • h) OT→PACU handover documentation and transfer tracing,
  • i) communication with lab, radiology, blood bank, pharmacy, ICU/ward, and PACU during downtime.

2.2 Excluded

  • 2.2.1 Anesthesia clinical documentation governance (managed by Anesthesia policy), except OT must coordinate interface records and ensure the OT pack supports transfer safety.
  • 2.2.2 Hospital billing and financial processes (covered by hospital downtime plan).

3.0 DEFINITIONS

  • 3.1 Downtime: Any period where EHR is unavailable or unreliable for clinical use, including partial outages (e.g., orders down, results down) and full outages.
  • 3.2 Planned Downtime: Scheduled maintenance outage with advance notice and preparation.
  • 3.3 Unplanned Downtime: Sudden outage without notice (hardware/software failure, network disruption, cyber incident). ISMP highlights the need to be ready for unanticipated downtime as an “emergency” event. (ECRI and ISMP)
  • 3.4 Downtime Pack (OT): Pre-printed, controlled paper forms and tools used to continue OT workflows safely during EHR downtime.
  • 3.5 Back-Entry: Entering essential information into the EHR after restoration, based on paper documentation created during downtime.
  • 3.6 Reconciliation: Verification that information captured on paper matches what was back-entered/scanned into the EHR, with sign-off by responsible roles.

4.0 POLICY STATEMENT

  • 4.1 OT shall maintain a current, controlled OT downtime pack that enables safe continuation of core perioperative processes without interruption. (Comprehensive downtime planning categories include communication, patient visits, documentation, prescription management, and orders/results considerations.) (ASPR TRACIE)
  • 4.2 During scheduled or unscheduled downtime, OT shall use approved paper documentation packs and continue safe surgery documentation, counts, specimens, implants, and handovers using the same verification discipline required during uptime.
  • 4.3 OT shall maintain two-identifier discipline and traceability controls because downtime has been associated with safety hazards such as impaired patient identification and information availability. (psnet.ahrq.gov)
  • 4.4 Back-entry into the EHR shall follow a controlled recovery and reconciliation process to ensure the downtime record is accurately represented after system restoration. Evidence-based downtime readiness work emphasizes training on downtime forms, audits, and drills to ensure recovery is effective. (HIMSS)
  • 4.5 Written downtime and recovery procedures shall be available, understood, and practiced to maintain consistent care when safety features (alerts, CDS, barcode scanning) are unavailable. (SAFER contingency planning emphasizes written policies and procedures for downtime and recovery.) (ASTP)

5.0 ROLES AND RESPONSIBILITIES

5.1 OT Charge Nurse (Downtime Coordinator – Shift)

  • 5.1.1 Declares OT downtime workflow activation when downtime criteria are met (see 6.0).
  • 5.1.2 Notifies all OT rooms and interface areas (PACU, lab, blood bank, radiology, pharmacy) and starts the Downtime Log.
  • 5.1.3 Ensures downtime packs are issued to affected rooms and that paper workflows are followed.
  • 5.1.4 Maintains a running OT patient/case status board (paper) and controls patient flow decisions during downtime.

5.2 Circulating Nurse (Per Case)

  • 5.2.1 Uses OT downtime forms to document the intraoperative record, counts, specimens, implants, medication/contrast/dye entries (OT scope), and handover.
  • 5.2.2 Ensures labeling discipline and chain-of-custody steps are maintained.
  • 5.2.3 Ensures paper forms are complete, legible, signed, and placed in the correct downtime packet for scanning/back-entry.

5.3 Scrub Nurse/Technologist

  • 5.3.1 Maintains sterile-field labeling discipline for medications/solutions and supports specimen and implant label preservation during downtime.

5.4 HIM/MOI Lead

  • 5.4.1 Defines which downtime forms must be scanned into the legal medical record and the required timelines.
  • 5.4.2 Defines late entry/amendment rules and downtime reconciliation sign-offs.
  • 5.4.3 Coordinates post-downtime scanning and record integrity checks.

5.5 IT Lead / Help Desk

  • 5.5.1 Confirms downtime status (partial vs full), estimated restoration pathway (without committing to times), and communicates recovery steps.
  • 5.5.2 Provides downtime notification and restoration notice to OT leadership and hospital operations per incident response pathway.

5.6 Laboratory / Blood Bank / Radiology / Pharmacy Liaisons

  • 5.6.1 Support downtime ordering/results communication using approved paper/fax/phone pathways and confirm read-back and documentation requirements.

6.0 DOWNTIME LEVELS AND ACTIVATION CRITERIA (OT OPERATIONAL DECISION)

6.1 Downtime Levels

6.1.1 Level 1: Partial Downtime (EHR accessible but key functions down)

  • a) orders entry unavailable, or
  • b) results viewing unavailable, or
  • c) printing/labeling unavailable, or
  • d) medication administration documentation unavailable.

6.1.2 Level 2: Full Downtime (EHR not accessible/unsafe to use)

  • a) login failures system-wide,
  • b) severe performance causing unsafe delays,
  • c) network outage affecting OT clinical functions,
  • d) cyber incident/containment action.

6.2 Activation Criteria

6.2.1 OT activates downtime workflow when:

  • a) IT declares downtime, OR
  • b) OT identifies that EHR function is unreliable enough to threaten safe verification/labeling/order communication, and IT confirms.

6.2.2 OT does not “wait and see” while care continues informally; delayed downtime activation can delay patient care and recovery processes (noted in downtime readiness work). (HIMSS)

6.3 Notification Standard

  • 6.3.1 Charge nurse notifies: OT rooms, PACU, lab, blood bank, radiology, pharmacy, ICU/ED as relevant.
  • 6.3.2 Communication method is defined (phone tree / group messaging / overhead code / incident command notice), consistent with the “communication” category emphasized in downtime planning guidance. (ASPR TRACIE)

7.0 DOWNTIME PACK CONTENTS (OT STANDARD)

7.1 Minimum OT Downtime Pack Forms

  • 7.1.1 Patient verification sheet (two identifiers + case number + wristband confirmation).
  • 7.1.2 Intraoperative OT record (paper).
  • 7.1.3 Surgical counts sheets (sponges/sharps/instruments).
  • 7.1.4 Specimen labels + specimen log + chain-of-custody form (where required).
  • 7.1.5 Implant traceability form + implant log insert sheet.
  • 7.1.6 OT medication/contrast/dye documentation tool (OT scope only) + sterile-field labeling prompt.
  • 7.1.7 OT→PACU handover form (paper).
  • 7.1.8 Downtime event log (room-level) and Downtime Case Tracking Board (charge nurse).

7.2 Pack Control

  • 7.2.1 Downtime packs are stored in defined locations (e.g., OT charge nurse station, each OR “red binder,” PACU station).
  • 7.2.2 Packs are version-controlled by HIM/MOI; obsolete forms are removed immediately.

8.0 PROCEDURE (OT SPECIFIC)

8.1 Downtime Activation Steps

  • 8.1.1 Charge nurse confirms downtime level and announces “OT Downtime Activated.”
  • 8.1.2 Start OT Downtime Log: date/time, downtime level, affected systems, rooms active.
  • 8.1.3 Issue downtime packs to each active OR and any OT holding areas receiving patients.
  • 8.1.4 Assign roles:
    • a) Downtime Coordinator (charge nurse),
    • b) Runner (communications and specimen transport if needed),
    • c) Label Control Lead (ensures labels are available and used correctly).

8.2 Patient Identification and Acceptance (Critical Control)

  • 8.2.1 Use two identifiers at each transition (OT acceptance, room entry, specimen labeling). Downtime events are associated with patient identification risk; therefore, identification is treated as “high-alert.” (psnet.ahrq.gov)
  • 8.2.2 If patient ID cannot be verified, the case is held and escalated (Stop-the-Line).
  • 8.2.3 Maintain a manual OT patient tracking board to avoid “lost patient” workflow failures.

8.3 Safe Surgery Documentation Continuity

  • 8.3.1 Continue Sign-In/Time-Out/Sign-Out governance using the paper OT record/checklists.
  • 8.3.2 Counts and discrepancy management continue on paper with signatures and time stamps.

8.4 Orders, Results, and Communication Pathways (During Downtime)

(Downtime planning guidance explicitly calls out orders/results/referrals as a major category to address.) (ASPR TRACIE)

8.4.1 Laboratory Orders

  • a) Use downtime requisition forms with two identifiers.
  • b) Specimen dispatch uses chain-of-custody where required.
  • c) Results are communicated via approved downtime channels (phone/fax/printed report), and the receiver documents read-back and time received.

8.4.2 Radiology / Imaging Orders

  • a) Use downtime imaging request forms.
  • b) Confirm patient identity verbally at handoff to radiology staff.
  • c) Critical results are communicated by phone with read-back and documented.

8.4.3 Blood Bank / Blood Product Requests

  • a) Use approved downtime blood request forms with two identifiers and indication.
  • b) Maintain “blood issued/received” documentation in OT downtime record and in blood bank system per their downtime rules.

8.4.4 Pharmacy / Medication Requests

  • a) Use downtime medication requisitions as defined by pharmacy policy.
  • b) High-alert and controlled medication controls remain in effect (double checks and accountability).

8.5 Medication Administration Documentation During Downtime (OT Scope)

  • 8.5.1 Recognize increased medication risk when barcode scanning/alerts are unavailable; PSNet event analyses note medication administration errors can be prevalent during downtime. (psnet.ahrq.gov)
  • 8.5.2 OT documents OT-managed medications/solutions/contrast/dyes on downtime medication form, including: name, concentration, amount, time, preparer initials where relevant.
  • 8.5.3 Sterile-field labeling rules remain mandatory (“no unlabeled syringes/bowls”).
  • 8.5.4 Controlled drugs (if OT-held) follow controlled drug paper register rules with witness signatures.

8.6 Specimens During Downtime

  • 8.6.1 Use downtime specimen labels (two identifiers + specimen site/laterality).
  • 8.6.2 Maintain specimen log and dispatch record; do not send unlabeled specimens.
  • 8.6.3 Results receipt is documented with time and read-back.

8.7 Implants/Prosthesis Traceability During Downtime

  • 8.7.1 Capture implant stickers/UDI details on the downtime implant traceability form.
  • 8.7.2 Maintain implant log insert; reconcile later to EHR registry during back-entry.
  • 8.7.3 Missing implant traceability documentation is treated as a serious documentation defect (escalate to charge nurse immediately).

8.8 OT → PACU Transfer During Downtime

  • 8.8.1 OT completes paper handover using standardized tool and confirms receiver acceptance.
  • 8.8.2 Ensure the paper packet accompanies the patient or is securely transferred per HIM rule, preventing loss of critical intraoperative data.

8.9 Downtime Storage and Record Security

  • 8.9.1 Completed paper forms are placed in a patient-specific downtime packet and stored in a secure controlled location (not left on counters).
  • 8.9.2 Protect confidentiality: do not display identifiers publicly; shred misprints per policy.

9.0 RECOVERY / RESTORATION / BACK-ENTRY PROCESS

(Downtime readiness literature emphasizes structured recovery/back-entry and reconciliation.) (HIMSS)

9.1 Restoration Announcement

  • 9.1.1 IT confirms restoration; charge nurse announces “Downtime Ended — Begin Recovery.”
  • 9.1.2 OT does not immediately stop paper documentation until IT and charge nurse confirm the EHR is stable and safe to use.

9.2 Back-Entry Principles

  • 9.2.1 Back-entry follows a defined sequence to reduce omissions and duplication.
  • 9.2.2 If the organization defines “essential backloading only,” the essential dataset must still ensure continuity of care and legal record integrity; a nursing downtime toolkit notes some organizations reduce burden by backloading essential clinical information while scanning approved paper forms into the EHR. (Vanderbilt University Medical Center)

9.3 Back-Entry Sequence (OT Minimum)

  • 9.3.1 Patient/case identification confirmation in EHR (correct encounter).
  • 9.3.2 OT intraoperative nursing record essential fields.
  • 9.3.3 Counts final status and any discrepancy actions.
  • 9.3.4 Specimen log entries and dispatch/receipt notes.
  • 9.3.5 Implant traceability and registry entries.
  • 9.3.6 OT medications/contrast/dye documentation (OT scope).
  • 9.3.7 OT→PACU handover completion record (time/receiver).
  • 9.3.8 Incident reports for downtime-related near misses/events (if not already filed).

9.4 Reconciliation and Sign-Off

  • 9.4.1 A second check is performed for high-risk items (counts status, specimens, implants) to verify accuracy of back-entry.
  • 9.4.2 Charge nurse (or designated validator) signs the reconciliation checklist for each case packet.

9.5 Scanning / Legal Medical Record Completion

  • 9.5.1 HIM/MOI governs scanning timelines and what becomes part of the permanent record.
  • 9.5.2 Paper forms are scanned and linked to the correct encounter; misfiled documents are corrected promptly.

10.0 TRAINING, DRILLS, AND READINESS

  • 10.1 OT staff receive initial training and annual refreshers on downtime forms, labeling discipline, order/results communication, and recovery workflow. Evidence-based downtime readiness work emphasizes training on downtime forms, audits, and drills. (HIMSS)
  • 10.2 Planned downtimes may be used for training and exercises; ASPR TRACIE materials encourage using planned outages and multiple scenarios to improve preparedness. (American Hospital Association)

11.0 INCIDENT REPORTING AND QPS LEARNING

  • 11.1 Any downtime-related safety event, near miss, identification confusion, specimen labeling issue, implant traceability gap, or medication documentation issue is reported and reviewed. (Downtime event analyses highlight safety hazards and support comprehensive downtime procedures and adherence.) (psnet.ahrq.gov)
  • 11.2 OT QPS reviews downtime events for system fixes: form redesign, better label printing strategy, clearer responsibilities, improved communication pathways.

12.0 AUDIT / KPIs

  • 12.1 Downtime pack readiness audit (monthly/quarterly): correct forms present, current version, stocked. (HIMSS)
  • 12.2 Downtime drill compliance: number of drills completed, attendance, gaps closed. (HIMSS)
  • 12.3 Back-entry completion time compliance (within facility-defined timeline).
  • 12.4 Error rate in reconciliation (mismatched encounter, missing implant log, missing specimen entry).
  • 12.5 Downtime incident rate and themes (patient ID risk, medication documentation risk). (psnet.ahrq.gov)

13.0 REFERENCES (ENGLISH)

  • 13.1 ASPR TRACIE Electronic Health Records and Downtime Procedures (planning categories/checklist: communication, documentation, orders/results, etc.). (ASPR TRACIE)
  • 13.2 SAFER Guides (HealthIT.gov) Contingency Planning (written downtime and recovery procedures). (ASTP)
  • 13.3 HIMSS Implementation of an Evidence-Based EHR Downtime Readiness and Recovery Plan (training, audits, drills, timely activation). (HIMSS)
  • 13.4 AHRQ PSNet Implications of EHR downtime: patient safety event reports (patient ID and medication error risks; need comprehensive procedures). (psnet.ahrq.gov)
  • 13.5 ISMP Newsletter Be ready for unanticipated EHR downtime (downtime as emergency; medication safety considerations). (ECRI and ISMP)
  • 13.6 A State-of-the-Art EHR Downtime and Uptime Procedure (lessons learned; reconciliation importance). (PMC)
  • 13.7 Nursing downtime preparedness toolkit (paper forms scanning and essential backloading considerations). (Vanderbilt University Medical Center)

14.0 APPENDICES (OT FORMS / TOOLS)

  • 14.1 Appendix A — OT Downtime Pack Index (Master List)
  • 14.2 Appendix B — OT Downtime Activation Log (Charge Nurse)
  • 14.3 Appendix C — OT Manual Patient/Cases Tracking Board Template
  • 14.4 Appendix D — Specimen Downtime Label Sheet + Specimen Log
  • 14.5 Appendix E — Implant Traceability Downtime Form + Implant Log Insert
  • 14.6 Appendix F — OT Medication/Contrast/Dye Downtime Documentation Tool
  • 14.7 Appendix G — OT→PACU Downtime Handover Form
  • 14.8 Appendix H — Back-Entry & Reconciliation Checklist (Per Case Packet)
  • 14.9 Appendix I — Downtime Drill Evaluation Form (Gap → Action → Owner → Due Date)

💬 التعليقات والملاحظات

أضف تعليقك

التقييم: ★★★★★